Gastrointestinal symptom burden in diabetic autonomic and peripheral neuropathy – A Danes cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Gastrointestinal symptom burden in diabetic autonomic and peripheral neuropathy – A Danes cohort study. / Kufaishi, Huda; Mizrak, Hatice Isik; Brock, Birgitte; Hansen, Tine Willum; Rossing, Peter; Hansen, Christian Stevns.

In: Journal of Diabetes and its Complications, Vol. 38, No. 5, 108745, 2024.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Kufaishi, H, Mizrak, HI, Brock, B, Hansen, TW, Rossing, P & Hansen, CS 2024, 'Gastrointestinal symptom burden in diabetic autonomic and peripheral neuropathy – A Danes cohort study', Journal of Diabetes and its Complications, vol. 38, no. 5, 108745. https://doi.org/10.1016/j.jdiacomp.2024.108745

APA

Kufaishi, H., Mizrak, H. I., Brock, B., Hansen, T. W., Rossing, P., & Hansen, C. S. (2024). Gastrointestinal symptom burden in diabetic autonomic and peripheral neuropathy – A Danes cohort study. Journal of Diabetes and its Complications, 38(5), [108745]. https://doi.org/10.1016/j.jdiacomp.2024.108745

Vancouver

Kufaishi H, Mizrak HI, Brock B, Hansen TW, Rossing P, Hansen CS. Gastrointestinal symptom burden in diabetic autonomic and peripheral neuropathy – A Danes cohort study. Journal of Diabetes and its Complications. 2024;38(5). 108745. https://doi.org/10.1016/j.jdiacomp.2024.108745

Author

Kufaishi, Huda ; Mizrak, Hatice Isik ; Brock, Birgitte ; Hansen, Tine Willum ; Rossing, Peter ; Hansen, Christian Stevns. / Gastrointestinal symptom burden in diabetic autonomic and peripheral neuropathy – A Danes cohort study. In: Journal of Diabetes and its Complications. 2024 ; Vol. 38, No. 5.

Bibtex

@article{82e3e81ebc6c4a31b03e029b657752b7,
title = "Gastrointestinal symptom burden in diabetic autonomic and peripheral neuropathy – A Danes cohort study",
abstract = "Objective: We investigated associations between gastrointestinal symptoms - evaluated as a combined weighted symptom score (CWSS) – Diabetic autonomic neuropathy (DAN), and distal symmetrical polyneuropathy (DSPN) in type 1 and type 2 diabetes. Research design and methods: Cross-sectional study in a tertiary outpatient clinic. CWSS was calculated based on questionnaires: gastroparesis composite symptom index (GCSI) and gastrointestinal symptom rating score (GSRS). DAN and DSPN were addressed using the composite autonomic symptom score 31 (COMPASS-31) questionnaire, cardiac autonomic reflex tests (CARTs), electrochemical skin conductance (ESC), vibration perception threshold (VPT), Michigan Neuropathy Screening Instrument (MNSI), pain- and thermal sensation. Analyses were adjusted for age, sex, diabetes duration, smoking, LDL-cholesterol, HbA1C and systolic blood pressure. Type 1 and type 2 diabetes were evaluated separately. Results: We included 566 with type 1 diabetes and 377 with type 2 diabetes. Mean ± SD age was 58 ± 15 years and 565 (59.9 %) were women. A high CWSS was present in 143 (25 %) with type 1 and 142 (38 %) with type 2 diabetes. The odds of DAN by COMPASS-31 (p < 0.001) were higher in the high score group. For type 1 diabetes, odds of cardiac autonomic neuropathy were higher in the high CWSS group. The odds of DSPN by VPT and MNSI in type 1 diabetes, and by ESC, VPT and pain sensation in type 2 diabetes were higher in the high CWSS group. Conclusions: A high symptom score was associated with neuropathy by COMPASS-31 and vibration perception. Gastrointestinal symptom burden associated inconsistently with other neuropathy tests between diabetes types.",
keywords = "Cardiovascular autonomic neuropathy, COMPASS-31, Complications, Diabetic neuropathies, Diabetic neuropathy, Distal peripheral neuropathy, Enteric nervous system, Enteropathy distal symmetric polyneuropathy, Gastrointestinal motility, Gastrointestinal symptoms, Gastroparesis, GCSI, GSRS, Type 1 diabetes, Type 2 diabetes",
author = "Huda Kufaishi and Mizrak, {Hatice Isik} and Birgitte Brock and Hansen, {Tine Willum} and Peter Rossing and Hansen, {Christian Stevns}",
note = "Publisher Copyright: {\textcopyright} 2024",
year = "2024",
doi = "10.1016/j.jdiacomp.2024.108745",
language = "English",
volume = "38",
journal = "Journal of Diabetes and its Complications",
issn = "1056-8727",
publisher = "Elsevier",
number = "5",

}

RIS

TY - JOUR

T1 - Gastrointestinal symptom burden in diabetic autonomic and peripheral neuropathy – A Danes cohort study

AU - Kufaishi, Huda

AU - Mizrak, Hatice Isik

AU - Brock, Birgitte

AU - Hansen, Tine Willum

AU - Rossing, Peter

AU - Hansen, Christian Stevns

N1 - Publisher Copyright: © 2024

PY - 2024

Y1 - 2024

N2 - Objective: We investigated associations between gastrointestinal symptoms - evaluated as a combined weighted symptom score (CWSS) – Diabetic autonomic neuropathy (DAN), and distal symmetrical polyneuropathy (DSPN) in type 1 and type 2 diabetes. Research design and methods: Cross-sectional study in a tertiary outpatient clinic. CWSS was calculated based on questionnaires: gastroparesis composite symptom index (GCSI) and gastrointestinal symptom rating score (GSRS). DAN and DSPN were addressed using the composite autonomic symptom score 31 (COMPASS-31) questionnaire, cardiac autonomic reflex tests (CARTs), electrochemical skin conductance (ESC), vibration perception threshold (VPT), Michigan Neuropathy Screening Instrument (MNSI), pain- and thermal sensation. Analyses were adjusted for age, sex, diabetes duration, smoking, LDL-cholesterol, HbA1C and systolic blood pressure. Type 1 and type 2 diabetes were evaluated separately. Results: We included 566 with type 1 diabetes and 377 with type 2 diabetes. Mean ± SD age was 58 ± 15 years and 565 (59.9 %) were women. A high CWSS was present in 143 (25 %) with type 1 and 142 (38 %) with type 2 diabetes. The odds of DAN by COMPASS-31 (p < 0.001) were higher in the high score group. For type 1 diabetes, odds of cardiac autonomic neuropathy were higher in the high CWSS group. The odds of DSPN by VPT and MNSI in type 1 diabetes, and by ESC, VPT and pain sensation in type 2 diabetes were higher in the high CWSS group. Conclusions: A high symptom score was associated with neuropathy by COMPASS-31 and vibration perception. Gastrointestinal symptom burden associated inconsistently with other neuropathy tests between diabetes types.

AB - Objective: We investigated associations between gastrointestinal symptoms - evaluated as a combined weighted symptom score (CWSS) – Diabetic autonomic neuropathy (DAN), and distal symmetrical polyneuropathy (DSPN) in type 1 and type 2 diabetes. Research design and methods: Cross-sectional study in a tertiary outpatient clinic. CWSS was calculated based on questionnaires: gastroparesis composite symptom index (GCSI) and gastrointestinal symptom rating score (GSRS). DAN and DSPN were addressed using the composite autonomic symptom score 31 (COMPASS-31) questionnaire, cardiac autonomic reflex tests (CARTs), electrochemical skin conductance (ESC), vibration perception threshold (VPT), Michigan Neuropathy Screening Instrument (MNSI), pain- and thermal sensation. Analyses were adjusted for age, sex, diabetes duration, smoking, LDL-cholesterol, HbA1C and systolic blood pressure. Type 1 and type 2 diabetes were evaluated separately. Results: We included 566 with type 1 diabetes and 377 with type 2 diabetes. Mean ± SD age was 58 ± 15 years and 565 (59.9 %) were women. A high CWSS was present in 143 (25 %) with type 1 and 142 (38 %) with type 2 diabetes. The odds of DAN by COMPASS-31 (p < 0.001) were higher in the high score group. For type 1 diabetes, odds of cardiac autonomic neuropathy were higher in the high CWSS group. The odds of DSPN by VPT and MNSI in type 1 diabetes, and by ESC, VPT and pain sensation in type 2 diabetes were higher in the high CWSS group. Conclusions: A high symptom score was associated with neuropathy by COMPASS-31 and vibration perception. Gastrointestinal symptom burden associated inconsistently with other neuropathy tests between diabetes types.

KW - Cardiovascular autonomic neuropathy

KW - COMPASS-31

KW - Complications

KW - Diabetic neuropathies

KW - Diabetic neuropathy

KW - Distal peripheral neuropathy

KW - Enteric nervous system

KW - Enteropathy distal symmetric polyneuropathy

KW - Gastrointestinal motility

KW - Gastrointestinal symptoms

KW - Gastroparesis

KW - GCSI

KW - GSRS

KW - Type 1 diabetes

KW - Type 2 diabetes

U2 - 10.1016/j.jdiacomp.2024.108745

DO - 10.1016/j.jdiacomp.2024.108745

M3 - Journal article

C2 - 38615421

AN - SCOPUS:85190092937

VL - 38

JO - Journal of Diabetes and its Complications

JF - Journal of Diabetes and its Complications

SN - 1056-8727

IS - 5

M1 - 108745

ER -

ID: 389506320